Great Lakes Advisors LLC Reduces Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Great Lakes Advisors LLC reduced its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.7% in the fourth quarter, Holdings Channel reports. The fund owned 11,093 shares of the medical equipment provider’s stock after selling 799 shares during the quarter. Great Lakes Advisors LLC’s holdings in Intuitive Surgical were worth $5,790,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently modified their holdings of ISRG. Berbice Capital Management LLC bought a new position in Intuitive Surgical during the fourth quarter valued at $26,000. BankPlus Trust Department purchased a new position in shares of Intuitive Surgical during the 4th quarter valued at $28,000. Kohmann Bosshard Financial Services LLC bought a new position in shares of Intuitive Surgical during the 4th quarter worth $31,000. MidAtlantic Capital Management Inc. purchased a new stake in Intuitive Surgical in the 3rd quarter worth about $33,000. Finally, Decker Retirement Planning Inc. bought a new stake in Intuitive Surgical in the 4th quarter valued at about $36,000. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $476.78 on Friday. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The firm’s fifty day moving average price is $568.47 and its 200-day moving average price is $531.22. The stock has a market cap of $169.82 billion, a P/E ratio of 74.38, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Myriam Curet sold 408 shares of the stock in a transaction dated Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total transaction of $240,618.00. Following the transaction, the executive vice president now directly owns 353 shares in the company, valued at approximately $208,181.75. This represents a 53.61 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Fredrik Widman sold 810 shares of the business’s stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $573.78, for a total value of $464,761.80. Following the completion of the sale, the vice president now owns 473 shares of the company’s stock, valued at $271,397.94. The trade was a 63.13 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 22,209 shares of company stock worth $11,928,127 over the last 90 days. Corporate insiders own 0.90% of the company’s stock.

Analysts Set New Price Targets

ISRG has been the subject of a number of research reports. Piper Sandler reiterated an “overweight” rating and set a $670.00 target price (up previously from $538.00) on shares of Intuitive Surgical in a research report on Friday, January 24th. Truist Financial raised their price objective on shares of Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a report on Friday, January 24th. JPMorgan Chase & Co. boosted their target price on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Bernstein Bank raised their price target on Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a report on Monday, January 27th. Finally, Citigroup boosted their price objective on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research note on Friday, January 24th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have given a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.